The Dark Genome Therapeutics market, valued at USD 2,155.7 million in 2024, is expected to register robust revenue CAGR of 23.8%.Request free copy of this report: 01, 2025 - Integration of AI and ...

Mursla’s AI Precision Medicine is built on the ability to isolate and analyze EVs which are secreted by specific organs into ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...

The conscious beauty revolution accelerates: 68% of brands adopt animal-free actives (Ecovia 2025) as #VeganSkincare surges ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...

Almost all cervical cancers are caused by human papillomaviruses (HPVs). In most cases, HPV DNA is integrated into the human genome. We found that tumor-specific, HPV-human DNA junctions are ...

The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...

TAIZHOU CITY, ZHEJIANG, CHINA, June 25, 2025 /EINPresswire.com/ -- The China National Intellectual Property Administration (CNIPA) announced the winners of the 25th China Patent Awards. Zhejiang ...

Spatial metabolomics is transforming our understanding of microbial systems by uncovering the localized molecular dynamics ...

The Innovation Center of NanoMedicine has summarized the results of its collaborative research with Professor Kanjiro ...